Green Cross, Daewoong Diverge In Global Expansion Push
This article was originally published in PharmAsia News
Executive Summary
Two leading South Korean pharma firms are moving in different directions as they aim to expand globally, with Daewoong Pharm agreeing to buy a controlling stake in HanAll BioPharma, while Green Cross has divested its entire stake in Ildong Pharm.